SensoDetect - Patent "BRAINSTEM RESPONSE-PC-EP" registered in several new EU countries
SensoDetect has been notified by the patent attorney AWA patent that the "BRAINSTEM RESPONSE PC-EP" patent with European patent no. 2 611 357 has now been completed in the following countries:
- Germany,
- France,
- UK,
- Switzerland-Liechtenstein,
- Netherlands,
- Denmark and
- Sweden.
"This is gratifying and we see that it strengthens the protection of our product and our portfolio increases the value both commercially and for the company as a whole," says Johan Olson, CEO SensoDetect AB (publ.).
Johan Olson
VD, SensoDetect Aktiebolag (publ)
Phone: +46 705 424600
e-mail: jo@sensodetect.com
SensoDetect highlights through patented equipment brain stem responses to audio stimuli in order to provide health care clear anomalies and patterns for use primarily within psychiatry. The goal is to increase efficiency in Psychiatry and thus the benefits for health care, society, patients and relatives.
Our Mission
Improve the lives of people with mental illness
Our Vision
Making ABR profiling tests with SensoDetect technology an integral part of setting diagnosis for mental illness
Our Value Proposition:
SensoDetect provides a complete audiogram for the brainstem, helping health care professional to set psychiatric diagnoses objectively and
cost effectively. This unique offering improves patients’ quality of life and reduces the economic impact on the health care system and society
Tags: